Paul Rivard, Chief Legal Officer at MyMD Pharmaceuticals, Inc. (MYMD), bought 25,000 shares at $1.12 ($28K) on 2023-08-17, disclosed to the SEC on 2023-08-18.
Open-market purchase of $28k MYMD by Chief Legal Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| MYMD | BUY | 2021-11-24 | $90K | — | Filing → |